These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28178989)

  • 1. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
    Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
    J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
    Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
    Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and RNA expression profiles in lung adenocarcinomas of never-smokers.
    Mansfield AS; Wang L; Cunningham JM; Jen J; Kolbert CP; Sun Z; Yang P
    Cancer Genet; 2015 May; 208(5):253-60. PubMed ID: 25650174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
    Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
    Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation markers of surfactant proteins in lung cancer.
    Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
    Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma.
    Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q
    J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
    Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
    Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
    Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
    Zhu XF; Zhu BS; Wu FM; Hu HB
    J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 CpG islands methylation in human lung cancer: a pilot study.
    Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
    Wang X; Shi D; Zhao D; Hu D
    Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma.
    Tian W; Li YS; Zhang JH; Li JJ; Gao JH
    DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.
    Vincent A; Omura N; Hong SM; Jaffe A; Eshleman J; Goggins M
    Clin Cancer Res; 2011 Jul; 17(13):4341-54. PubMed ID: 21610144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
    Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
    Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.